English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/147737
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


A GSK-3b modulator delays photoreceptor cell death and preserves visual function in the rd10 mouse model of retinitis pigmentosa

AuthorsHernández-Sánchez, Catalina ; Villarejo-Zori, Beatriz ; Zaldívar-Díez, Josefa; Marchena, Miguel; Gil, Carmen ; Villa, Pedro de la; Martínez, Ana ; De la Rosa, Enrique J.
Issue DateMay-2016
PublisherAssociation for Research in Vision and Ophthalmology
CitationARVO 2016 (Seatle) "Research: A Vision for Hope" (pág.5)
AbstractRetinitis pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies that lead to blindness. Photoreceptor cell death, reactive gliosis and retinal inammation are common features in animal models of the disease. The enzyme Glycogen Synthase Kinase-3 Beta (GSK-3b) is involved in inammatory processes associated to diverse neurodegenerative pathologies. The aim of our study is to test in the rd10 mouse whether the GSK-3b inhibitor VP3.15 (a small heterocyclic molecule) is a potential therapeutic treatment for RP.
Description1 p.
Publisher version (URL)https://cld.bz/YtGLFmy#
Appears in Collections:(CIB) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
E. de la Rosa_abstract-pag.5 .pdfComunicación Congreso189,91 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.